Brazil Seeks Reinstatement on EU Antimicrobial Compliance List Amid Meat Import Dispute Anthropic Poised to Reach 109 Billion in Q2 Revenue First Profitable Quarter Possible Catalyst Pharmaceuticals Q1 2026 Earnings EPS Surpasses Estimates by 75 ACGLN Q1 2026 Earnings Preferred Shares React to Slight EPS Miss Microsoft in Talks to Supply Custom AI Chips to Anthropic After 5 Billion Investment